Clinical Study

CORDIART provides triple heart protection

Format: PDF file | Document type: Clinical Study | Promoted Content

This content is provided by BioActor, and any views and opinions expressed do not necessarily reflect those of

CORDIART provides triple heart protection

The benefits of CORDIART, a natural rutinoside extract, on the maintenance of a good cardiovascular health have been assessed in several clinical studies. A newly completed clinical study further underpins CORDIART’s triple action: 1) maintenance of endothelial flexibility, 2) reduction of plaques formation, 3) improved control of platelet activation and adhesion molecules.

If you want to have more information about CORDIART, contact us ( or have a look at

Latest content from BioActor

Related resources from BioActor

Show more

Supplier info centre